I hope you are right on etheRNA. Isn't IO Biotech a RNA based immuno oncology Co too? I'm just wondering the lack of update with etheRNA as with Imugene before until totally out of the picture. I wish Mr. Kempers will make a change in his way in communicating with us shareholders. :(
Like I said Brother gotta be some kinda otc derivatives in here somewhere
Pieter Leentvaar
Global Program Manager at Catalent Pharma Solutions
Legal & Finance Associate
ANERGIS The Future of Allergy Treatment: Ultra-Fast Desensitization
Juni 2014 – Nov. 2015 1 Jahr 6 Monate
Lausanne Area, Switzerland
All Options Helvetia AG 1 Jahr 11 Monate
Senior Equity Derivatives Trader
Okt. 2007 – Sep. 20081 Jahr
Zug, Switzerland
Starting up a Swiss trading team
Marketmaker in Swiss single stock options
Equity Derivatives Trader Nov. 2006 – Okt. 20071 Jahr
Amsterdam Area, Netherlands
Marketmaker in single stock options German market
Derivatives and cash trader Optiver Holding BV Nov. 1997 – Apr. 20024 Jahre 6 Monate
Amsterdam Area, Netherlands
Marketmaker in single stock options both on Amsterdam trading floor and through screen trading Cross border and currency volatility arbitrage Stock arbitrage ETF arbitrage